We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drugmaker GlaxoSmithKline Plc has asked U.S. pharmacists to warm patients about the unpleasant side effects that may occur with a potential over-the-counter diet drug.
A Cambridge company that pays doctors to post medical observations on its website, including reports of drug side effects, has quickly incurred the wrath of pharmaceutical makers.
Bayer AG said Friday it suspended two employees involved in the decision to withhold data from federal health officials showing the company's drug Trasylol can cause deadly side effects.
Retail giant Wal-Mart is expanding its generic drug discount program to the entire state of Florida four months ahead of schedule and adding to the list of drugs included in the program, but one analyst is questioning the move's impact on the market.
A clinical investigator failed to examine a subject who showed up for a scheduled study visit complaining of indigestion and turned out to be having a heart attack, according to a warning letter from the FDA.
Sen. Chuck Grassley (R-Iowa) is calling on the Centers for Medicare & Medicaid Services (CMS) to clarify its new policy on compounded inhalation drugs, following the agency's earlier decision to change how it reimburses for the products.
The U.S. Securities and Exchange Commission is hunting for investors suspected of profiting from advanced knowledge of GlaxoSmithKline PLC's takeover bid for CNS Inc.